402 related articles for article (PubMed ID: 26226195)
21. Autoimmune associations and autoantibody screening show focused recognition in patient subgroups with generalized myasthenia gravis.
Klein R; Marx A; Ströbel P; Schalke B; Nix W; Willcox N
Hum Immunol; 2013 Sep; 74(9):1184-93. PubMed ID: 23792059
[TBL] [Abstract][Full Text] [Related]
22. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y
J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794
[TBL] [Abstract][Full Text] [Related]
23. Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor.
Vrolix K; Fraussen J; Losen M; Stevens J; Lazaridis K; Molenaar PC; Somers V; Bracho MA; Le Panse R; Stinissen P; Berrih-Aknin S; Maessen JG; Van Garsse L; Buurman WA; Tzartos SJ; De Baets MH; Martinez-Martinez P
J Autoimmun; 2014 Aug; 52():101-12. PubMed ID: 24439114
[TBL] [Abstract][Full Text] [Related]
24. Surgery of myasthenia gravis associated or not with thymoma: a retrospective study of 43 cases.
El Hammoumi M; Arsalane A; El Oueriachi F; Kabiri el H
Heart Lung Circ; 2013 Sep; 22(9):738-41. PubMed ID: 23548337
[TBL] [Abstract][Full Text] [Related]
25. Long-term change of anti-acetylcholine receptor antibody in patients with myasthenia gravis after thymectomy.
Hayashi M; Manabe K; Takaoka T; Yamada I; Kida K; Matsuda H; Yoshinaga J
Acta Paediatr Jpn; 1995 Jun; 37(3):362-6. PubMed ID: 7645389
[TBL] [Abstract][Full Text] [Related]
26. Myasthenia gravis: a long term follow-up study of Swedish patients with specific reference to thymic histology.
Tsinzerling N; Lefvert AK; Matell G; Pirskanen-Matell R
J Neurol Neurosurg Psychiatry; 2007 Oct; 78(10):1109-12. PubMed ID: 17353257
[TBL] [Abstract][Full Text] [Related]
27. A comparison of long-term post-thymectomy outcome of anti-AChR-positive, anti-AChR-negative and anti-MuSK-positive patients with non-thymomatous myasthenia gravis.
Ponseti JM; Caritg N; Gamez J; López-Cano M; Vilallonga R; Armengol M
Expert Opin Biol Ther; 2009 Jan; 9(1):1-8. PubMed ID: 19063688
[TBL] [Abstract][Full Text] [Related]
28. [Anesthetic considerations for thymectomy in a patient having an anti-acetylcholine receptor antibody without myasthenia gravis].
Koshida T; Hara K; Obara G; Sata T
Masui; 2008 Aug; 57(8):993-5. PubMed ID: 18710007
[TBL] [Abstract][Full Text] [Related]
29. Seronegative myasthenia gravis: disease severity and prognosis.
Romi F; Aarli JA; Gilhus NE
Eur J Neurol; 2005 Jun; 12(6):413-8. PubMed ID: 15885043
[TBL] [Abstract][Full Text] [Related]
30. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
[TBL] [Abstract][Full Text] [Related]
31. Thymectomy in myasthenia gravis: comparison of outcome in Santiago, Cuba and Nottingham, UK.
Shahrizaila N; Pacheco OA; Vidal DG; Miyares FR; Wills AJ
J Neurol; 2005 Oct; 252(10):1262-6. PubMed ID: 16200466
[TBL] [Abstract][Full Text] [Related]
32. Thymocyte Fas expression is dysregulated in myasthenia gravis patients with anti-acetylcholine receptor antibody.
Moulian N; Bidault J; Truffault F; Yamamoto AM; Levasseur P; Berrih-Aknin S
Blood; 1997 May; 89(9):3287-95. PubMed ID: 9129034
[TBL] [Abstract][Full Text] [Related]
33. Factors influencing the outcome of transsternal thymectomy for myasthenia gravis.
Huang CS; Hsu HS; Huang BS; Lee HC; Kao KP; Hsu WH; Huang MH
Acta Neurol Scand; 2005 Aug; 112(2):108-14. PubMed ID: 16008537
[TBL] [Abstract][Full Text] [Related]
34. A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis.
Zisimopoulou P; Evangelakou P; Tzartos J; Lazaridis K; Zouvelou V; Mantegazza R; Antozzi C; Andreetta F; Evoli A; Deymeer F; Saruhan-Direskeneli G; Durmus H; Brenner T; Vaknin A; Berrih-Aknin S; Frenkian Cuvelier M; Stojkovic T; DeBaets M; Losen M; Martinez-Martinez P; Kleopa KA; Zamba-Papanicolaou E; Kyriakides T; Kostera-Pruszczyk A; Szczudlik P; Szyluk B; Lavrnic D; Basta I; Peric S; Tallaksen C; Maniaol A; Tzartos SJ
J Autoimmun; 2014 Aug; 52():139-45. PubMed ID: 24373505
[TBL] [Abstract][Full Text] [Related]
35. Correlation of anti-acetylcholine receptor antibody levels and long-term outcomes of juvenile myasthenia gravis in Taiwan: a case control study.
Chou CC; Su IC; Chou IJ; Lin JJ; Lan SY; Wang YS; Kong SS; Chen YJ; Hsieh MY; Hung PC; Wang HS; Chou ML; Lin KL;
BMC Neurol; 2019 Jul; 19(1):170. PubMed ID: 31319795
[TBL] [Abstract][Full Text] [Related]
36. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
Kawanami S; Tsuji R; Oda K
Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620
[TBL] [Abstract][Full Text] [Related]
37. Anti-acetylcholine-receptor antibody concentrations after thymectomy in patients with myasthenia gravis.
Seybold ME; Baergen RN; Nave B; Lindstrom JM
Br Med J; 1978 Oct; 2(6144):1051-3. PubMed ID: 709215
[TBL] [Abstract][Full Text] [Related]
38. Factors affecting response to thymectomy for myasthenia gravis.
Rubin JW; Ellison RG; Moore HV; Pai GP
J Thorac Cardiovasc Surg; 1981 Nov; 82(5):720-8. PubMed ID: 7300404
[No Abstract] [Full Text] [Related]
39. Transsternal thymectomy for myasthenia gravis: surgical outcome.
Kattach H; Anastasiadis K; Cleuziou J; Buckley C; Shine B; Pillai R; Ratnatunga C
Ann Thorac Surg; 2006 Jan; 81(1):305-8. PubMed ID: 16368387
[TBL] [Abstract][Full Text] [Related]
40. Thymectomy and antimuscle antibodies in nonthymomatous myasthenia gravis.
Romi F; Gilhus NE; Varhaug JE; Myking A; Skeie GO; Aarli JA
Ann N Y Acad Sci; 2003 Sep; 998():481-90. PubMed ID: 14592917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
